Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PSMG3 pseudogene 2 (PSMG3P2) is annotated as a pseudogene, meaning it is a non-coding genomic element similar in sequence to the protein-coding gene PSMG3, but lacking coding potential and functional protein expression. Pseudogenes such as PSMG3P2 are generally not considered functional targets for drug discovery, are not known to encode proteins, are not part of canonical signaling, regulatory, or structural pathways, and have not been identified as actionable biomarkers, therapeutic targets, or disease drivers. The biological functions, disease roles, and interactions relevant to pseudogenes are generally uncharacterized unless specific regulatory RNA effects are discovered, which is not the case for PSMG3P2 based on available scientific data. PSMG3P2 should not be confused with PSMG3 (Proteasome assembly chaperone 3, also known as PAC3), which is a functional gene encoding a chaperone protein involved in proteasome assembly and has some implications in cancer biology[1][2][3]. No evidence supports PSMG3P2 as a protein, therapeutic target, or biomarker, and there is no reported drug interaction. If information is required on the functional gene (PSMG3), refer to that entity, not the pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PSMG3 pseudogene 2 (PSMG3P2).